Condition
Aphakia, Postcataract
Total Trials
3
Recruiting
0
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05821101Not ApplicableActive Not RecruitingPrimary
Clinical Outcomes of Clareon Vivity Intraocular Lens With Mini-Monovision Approach
NCT06363448Not ApplicableCompletedPrimary
Yamani Technique Versus Proline Mesh for Intraocular Lens Scleral Fixation in Aphakia
NCT04005651Not ApplicableCompletedPrimary
Safety and Efficacy of a Trifocal Intraocular Lens (IOL) POD L GF in Comparison With a Multifocal and a Monofocal IOL
Showing all 3 trials